Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer
A replication-competent adenovirus was successfully designed to replicate conditionally in PSA-positive and PSMA-positive prostate cancer cells, and this construct would be expected to have potent antitumor effects and deserves more extensive investigation.
M. Kee
· 0 citations